First patient dosed in study investigating roginolisib + dostarlimab +/- docetaxel in patients with NSCLC who have progressed on prior immunotherapy/chemo Study will evaluate ...

A leading psychologist exposes widespread psychological myths, urging a rethink of commonly accepted ideas about personality, ...

Glucagon-like peptide-1 receptor agonists improve cardiovascular outcomes and reduce mortality in patients with type 2 ...

Disadvantaged neighborhoods affect brain development in children, raising their vulnerability to stress, depression, and ...

Ultra-processed baby foods disrupt gut bacteria in infants, increasing the risk of inflammation, allergies, obesity, and ...

Plasmodium falciparum infection increases the risk of Burkitt lymphoma (cancer) in children by triggering enzyme changes that ...

U.S. adults know plant-based diets improve health, but only 20% of doctors discuss it—despite strong evidence of disease ...

International No Diet Day promotes body positivity, challenges diet culture, and supports mental and physical health through ...

A global tribute to humanitarian service, celebrating the life-saving efforts of Red Cross and Red Crescent volunteers ...

Genesis+HOCl Brings Nature's Germ Fighter to U.S. Homes and Businesses — Offers Free Atomizer Giveaway While the public has long relied on filters, air purifiers, and chemical disinfectants to clean ...

Aspen Neuroscience has released 6-month data from the first three patients dosed in the ASPIRO Phase 1/2a trial of ANPD001, an investigational autologous dopaminergic neuronal precursor cell (DANPC) ...